Skip to main navigation
Skip to search
Skip to main content
University of Canberra Research Portal Home
Home
Profiles
Research output
Projects
Press/Media
Activities
Research units
Prizes
Student theses
Search by expertise, name or affiliation
Immune modulation via epigenetic targeting to overcome immune checkpoint inhibitor resistance
Thiru Prasanna, Fan Wu, Desmond Yip, Sudha Rao
Science
Research output
:
Contribution to journal
›
Editorial
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immune modulation via epigenetic targeting to overcome immune checkpoint inhibitor resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immune Regulation
100%
Epigenetic Targeting
100%
Solid Organ Malignancy
100%
Immune Checkpoint Inhibitor Resistance
100%
Survival Benefit
50%
Combination Immunotherapy
50%
Immune Checkpoint Inhibitors
50%
Best Response
50%
Anticancer Therapy
50%
Anti-PD-1
50%
Melanoma Patients
50%
PD-1 Inhibition
50%
US FDA
50%
Anti-CTLA-4
50%
Suboptimal Response
50%
Medicine and Dentistry
Immune Checkpoint Inhibitor
100%
Immunotherapy
100%
Immunomodulation
100%
Cancer
66%
Melanoma
33%
Cancer Treatment
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immune Checkpoint Inhibitor
100%
Immunotherapy
100%
Melanoma
33%
Cytotoxic T Lymphocyte Antigen 4
33%